- Home
- TBLD vs SRDX Comparison
TBLD vs SRDX Comparison
Compare TBLD & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBLD
- SRDX
- Stock Information
- Founded
- TBLD 2021
- SRDX 1979
- Country
- TBLD United States
- SRDX United States
- Employees
- TBLD N/A
- SRDX N/A
- Industry
- TBLD Investment Managers
- SRDX Medical/Dental Instruments
- Sector
- TBLD Finance
- SRDX Health Care
- Exchange
- TBLD Nasdaq
- SRDX Nasdaq
- Market Cap
- TBLD 530.3M
- SRDX 562.6M
- IPO Year
- TBLD N/A
- SRDX 1998
- Fundamental
- Price
- TBLD $16.78
- SRDX $36.88
- Analyst Decision
- TBLD
- SRDX Hold
- Analyst Count
- TBLD 0
- SRDX 4
- Target Price
- TBLD N/A
- SRDX $43.00
- AVG Volume (30 Days)
- TBLD 99.9K
- SRDX 276.5K
- Earning Date
- TBLD 01-01-0001
- SRDX 01-30-2025
- Dividend Yield
- TBLD 7.85%
- SRDX N/A
- EPS Growth
- TBLD N/A
- SRDX N/A
- EPS
- TBLD N/A
- SRDX N/A
- Revenue
- TBLD N/A
- SRDX $126,078,000.00
- Revenue This Year
- TBLD N/A
- SRDX $13.75
- Revenue Next Year
- TBLD N/A
- SRDX $13.67
- P/E Ratio
- TBLD N/A
- SRDX N/A
- Revenue Growth
- TBLD N/A
- SRDX N/A
- 52 Week Low
- TBLD $13.44
- SRDX $25.17
- 52 Week High
- TBLD $16.26
- SRDX $42.44
- Technical
- Relative Strength Index (RSI)
- TBLD 60.78
- SRDX 34.51
- Support Level
- TBLD $16.19
- SRDX $34.76
- Resistance Level
- TBLD $16.50
- SRDX $37.08
- Average True Range (ATR)
- TBLD 0.23
- SRDX 0.90
- MACD
- TBLD 0.06
- SRDX -0.33
- Stochastic Oscillator
- TBLD 95.16
- SRDX 38.90
About TBLD Thornburg Income Builder Opportunities Trust
Thornburg Income Builder Opportunities Trust is a diversified, closed-end management investment company. The Trust's investment objective is to provide current income. The Trust will seek to achieve its investment objective by investing, directly or indirectly, at least 80% of its Managed Assets.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.